Drugs causing prostate-specific antigen changes: the food and drug administration adverse event reporting system combined with Mendelian randomization analysis
This study provided a basis for better understanding the impact of medications on prostate health, helping to avoid overdiagnosis or underdiagnosis of high-risk patients. However, research still requires larger-scale validation and in-depth exploration.
Authors
- R. Wang (ORCID: https://orcid.org/0000-0002-5059-8456)
- Zhisheng Jia (ORCID: https://orcid.org/0009-0002-3913-1078)
- Xin Jiang (ORCID: https://orcid.org/0000-0003-4762-3101)
- Wei Zhang (ORCID: https://orcid.org/0000-0001-5661-0789)
- Yuepeng Ma
- Caoyang Hu
- Zhifang Ma (ORCID: https://orcid.org/0000-0003-4946-2276)
- Hua Tian (ORCID: https://orcid.org/0000-0003-3837-9071)
- Xin Wang (ORCID: https://orcid.org/0000-0002-5522-8681)
Institutions
- Shanxi Medical University (CN)
- First Hospital of Shanxi Medical University (CN)
- Shanghai Jinyuan Senior High School (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-09-14
- DOI
- https://doi.org/10.1080/14740338.2024.2405577
- Primary Topic
- Statistical Methods in Clinical Trials
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shanxi Scholarship Council of China